RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재
      • KCI등재

        개정 군인사법 제54조의2 제2항 해석론: 실무상 쟁점을 중심으로

        탁경국 민주주의법학연구회 2023 민주법학 Vol.- No.83

        The Art. 54-2 (Classification of Persons in Military Service Killed in Action), para. 2 was newly inserted on Jan. 4, 2022 in the Military Personnel Management Act(hereinafter as “MPMA”) and the Art. 60-23 of the (Presidential) Enforcement Decree for this Act on Jun. 30, 2022. This article deals with the interpretation of these provisions. The Art. 54-2, Para. 2 provides that “Where a military personnel dies during his or her compulsory service period, he or she shall be classified as a public official who died in the line of duty[…]. Provided that where a person falls under any ground prescribed by Presidential Decree, such as death by intent or gross negligence or death caused by an unlawful act, the person may be classified as a person who died for ordinary reasons.” Although these provisions are still based on a fault-based liability system, this revision can be understood that, when it comes to the deaths of soldiers in the compulsory service period, a social consensus has been reached that the responsibility of the state should be guaranteed through shifting the burden of proof on the cause of death to the state. From this perspective of state responsibility, I would like to show what are better interpretations of the current controversial provisions, considering the newly developed precedents and practical examples of state organizations. My intention is to present uniform regulations about the death of soldiers, among MPMA, Military Accident Compensation Act, Act On Support For Persons Eligible For Veteran’s Compensation.

      • Multidose Use of Heparin and Lidocaine Vials: a Study in Stability and Sterility

        김보리,오은숙,이정선,황보신이,박정준,탁경국,김기환 한국병원약사회 2008 병원약사회지 Vol.25 No.1

        Heparin and lidocaine in Kangnam St. Mary's hospital are single-dose vials, but these are used as multi-dose vial when the dosage is low. There was no study about the stability of multi-dose use, so we studied about stability and sterility of multi-dose use of heparin and lidociane. Heparin inj® 1,000IU/ml and 5,000IU/ml vials were stored at room temperature, underrefrigeration, light protection and room light. We checked contents, external appearance and pH for the stability of heparin and the sterility was determined by checking the microbial growth at room temperature and under refrigeration at initial, 3rd, 7th, 15th day. The samples of lidocaine 2% inj® were collected in room temperature and under refrigeration to assess the stability and sterility of lidocaine and were checked contents and microbial growth. In result, heparin 1,000IU/ml, 5,000IU/ml and lidocaine did not change significantly for 15days and no microbial growth was noted in all conditions. Although both heparin and lidocaine were stable in 15days, this study has limitations: the small number of samples and difference of environment between laboratory and ward. More study about multi-dose use of injectable drugs is needed.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼